Results 161 to 170 of about 374,401 (266)

Benchmarking Time-Series Artificial Intelligence Architectures for Wearable Sensor-Based Fall Prediction: A Synthetic Data Simulation Framework. [PDF]

Sensors (Basel)
Sykes ER, Maghsoudimehrabani M, Al-Shanoon A.   +2 more
europepmc   +1 more source

ON THE ABSOLUTE STABILITY OF SAMPLED-DATA CONTROL SYSTEMS [PDF]

Proceedings of the National Academy of Sciences, 1963
openaire   +2 more sources

CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3

Molecular Oncology, EarlyView.
PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh, Nitzan Medina‐Itzhaki, Milena Chekov, Eden Gal‐Swisa, Roba Gabesh‐Wahabi, Inbar Savyon, Inna Naroditsky, Hilary A. Kenny, Basem Fares, Lina Korsensky, Einav Girsh, Liron Berger, Ruth Perets   +12 more
wiley   +1 more source

Finite-Aperture Limits for Yaw Estimation in Confocal Non-Line-of-Sight Imaging. [PDF]

J Imaging
Romanelli R, Livi LF, Pepe FV, Sorelli G, Mauri E, D'Angelo M, Proietti M.   +6 more
europepmc   +1 more source

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

Molecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau, Lilian G. Zhai, Ryunosuke Hoshi, Zackary Rousseau, Abraam Zakhary, Yin Fang Wu, Rola M. Saleeb, Heyu Ni, Kelsie L. Thu   +8 more
wiley   +1 more source

The Microbiology and Geochemistry of the Shallow-Water Hydrothermal Vents of the Gulf of Naples, Italy. [PDF]

Environ Microbiol
Barosa B, Celentano C, Migliaccio F, Diana SC, Silva ACP, Selci M, Tonietti L, Bastoni D, Cascone M, Bastianoni A, Correggia M, di Iorio L, Price R, Caliro S, Milazzo M, Aiuppa A, Vetriani C, Cordone A, Giovannelli D.   +18 more
europepmc   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

Fast sampling of protein conformational dynamics. [PDF]

Sci Adv
Sauer MA, Mondal S, Neff B, Maiti S, Heyden M.   +4 more
europepmc   +1 more source

Heterozygous loss‐of‐function alleles associate the conserved 3′‐5′ exoribonuclease EXOSC10 with hypersensitivity to the anticancer drug 5‐fluorouracil

Molecular Oncology, EarlyView.
EXOSC10, an essential nuclear RNA exosome‐associated 3′‐5′ exoribonuclease, is inhibited by the anticancer drug 5‐fluorouracil (5‐FU), and EXOSC10 depletion increases 5‐FU sensitivity. The colon‐cancer variant EXOSC10S402T, located in a proteolysis motif, is stable and nuclear but nonfunctional in vivo.
Radhika Sain, Yann Le Page, Frédéric Percevault, Emmanuelle Becker, Luc Negroni, Almudena Fernandez, Marta Cantero, Diego Muñoz‐Santos, Lluís Montoliu, Cyrille Garnier, Michael Primig   +10 more
wiley   +1 more source

Chromosome-scale, single haploid assembly of achiote (Bixa orellana). [PDF]

BMC Genom Data
Lieberman MC, Aguilar-Espinosa M, Chan-Rodriguez D, Coma L, Rivera-Madrid R, Henry IM.   +5 more
europepmc   +1 more source